Newborn Screening for Congenital Cytomegalovirus (CMV): Stop CMV Act 2024
This law aims to allow hospitals to screen newborns (up to 21 days old) for congenital Cytomegalovirus (CMV), a leading cause of birth defects and developmental issues. It provides federal grants to states to establish testing procedures, educate parents and healthcare providers, and fund critical research into better diagnostics and treatments. This initiative helps ensure earlier detection and intervention for affected infants, potentially mitigating long-term health consequences.
Key points
Allows hospitals to administer screening tests for congenital CMV to all infants 21 days old or less.
Provides federal funding to states to develop testing standards, track results, and disseminate educational materials to parents and the public.
Authorizes increased research funding for the National Institutes of Health (NIH) focused on new screening techniques, prevention, treatments, and vaccine development for CMV.
Expired
Citizen Poll